tradingkey.logo
搜索

ICU Medical Inc

ICUI
添加自选
165.610USD
+4.150+2.57%
收盘 07-28 16:00美东报价延迟15分钟
4.14B总市值
88.22市盈率 TTM

关于 ICU Medical Inc 公司

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.

ICU Medical Inc简介

公司代码ICUI
公司名称ICU Medical Inc
上市日期Mar 31, 1992
CEOJain (Vivek)
员工数量15000
证券类型Ordinary Share
年结日Mar 31
公司地址951 Calle Amanecer
城市SAN CLEMENTE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编92673-6212
电话19493662183
网址https://www.icumed.com/
公司代码ICUI
上市日期Mar 31, 1992
CEOJain (Vivek)

ICU Medical Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
279.17K
+44.40%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
71.75K
+57.70%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
46.31K
+86.85%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
22.48K
-9.44%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
9.71K
+12.91%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
6.00K
+20.89%
Ms. Laurie Hernandez
Ms. Laurie Hernandez
Independent Director
Independent Director
4.86K
+25.79%
Ms. Kolleen T. Kennedy
Ms. Kolleen T. Kennedy
Independent Director
Independent Director
4.54K
+27.63%
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
4.51K
+27.83%
Mr. John Mills
Mr. John Mills
Investor Relations
Investor Relations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
279.17K
+44.40%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
71.75K
+57.70%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
46.31K
+86.85%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
22.48K
-9.44%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
9.71K
+12.91%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
6.00K
+20.89%

常见问题

ICU Medical Inc的前五大股东是谁?

ICU Medical Inc 的前五大股东如下:Mr. Vivek Jain

有多少机构持有ICU Medical Inc(ICUI)的股份?

截至2026Q1,共有628家机构持有ICU Medical Inc的股份,合计持有的股份价值约为28.59M,占公司总股份的114.41%。与2025Q4相比,机构持股有所增加,增幅为638369.00。

哪个业务部门对ICU Medical Inc的收入贡献最大?

在2026Q1,Infusion Consumables业务部门对ICU Medical Inc的收入贡献最大,创收1.11B,占总收入的49.71%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有